Biobanks are acknowledged as a necessary and powerful resource for R&D with access to millions of samples and the associated data collected with them, but creating a sustainable framework for biobanking is a critical challenge for them to overcome.
Ahead of Global Biobanking 2015, Pharma IQ spoke to key speakers Heli Salimen-Mankonen, Research Director, Auria Biobank and Francisco de Luna, Deputy Coordinator of the National Biobank Network, CNIO about enhancing sustainability and the steps they are taking to create a successful sustainable biobank.
Pharmaceuticals & Biotechnology Editor | 03/19/2015
RECOMMENDED
MSD announces Phase III data on investigational treatment to lower LDL Cholesterol (LDL-C)
2025-11-17
AI for Pharma & Healthcare 2025
2025-06-18
Upcoming Events
Pharma Contract Manufacturing
23 - 25 March 2026
Mercure Hotel MOA Berlin, Germany
Register Now |
View Agenda |
Learn More